EP 1390348 A1 20040225 - 5-CYANO-1H-INDOLE DERIVATIVES AS ANTAGONISTS OF THE INTERLEUKINE-8 RECEPTORS
Title (en)
5-CYANO-1H-INDOLE DERIVATIVES AS ANTAGONISTS OF THE INTERLEUKINE-8 RECEPTORS
Title (de)
5-CYANO-1H-INDOL-DERIVATE ALS INTERLEUKIN-8 REZEPTOREN ANTAGONISTEN
Title (fr)
DERIVES DE 5-CYANO-1H-INDOLE ANTAGONISTES DES RECEPTEURS DE L'INTERLEUKINE-8
Publication
Application
Priority
- FR 0201647 W 20020516
- FR 0106506 A 20010517
Abstract (en)
[origin: WO02092568A1] The invention concerns 5-cyano-<i>1H</i>-indole derivatives of formula (I), wherein: R>1<, R>2<, X and n are such as defined in Claim 1, as well as their pharmaceutically acceptable salts, solvates, and hydrates. The invention also concerns pharmaceutical compositions containing them, and their use for preparing medicines for preventive or curative treatment of diseases mediated by the activation of the CXCR2 receptor of interleukine-8 and chemokines of the same family.
IPC 1-7
IPC 8 full level
A61K 31/405 (2006.01); A61P 1/00 (2006.01); A61P 1/02 (2006.01); A61P 1/04 (2006.01); A61P 7/00 (2006.01); A61P 7/02 (2006.01); A61P 9/00 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/02 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 33/06 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01); C07D 209/18 (2006.01); C07D 409/04 (2006.01)
CPC (source: EP KR US)
A61P 1/00 (2017.12 - EP); A61P 1/02 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 33/06 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 209/18 (2013.01 - EP US); C07D 209/42 (2013.01 - KR); C07D 409/04 (2013.01 - EP US)
Citation (search report)
See references of WO 02092568A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02092568 A1 20021121; BR 0207438 A 20040810; CA 2447184 A1 20021121; CN 1496348 A 20040512; CZ 20032260 A3 20031112; EP 1390348 A1 20040225; FR 2824826 A1 20021122; FR 2824826 B1 20031107; JP 2004534034 A 20041111; KR 20030094255 A 20031211; US 2005100902 A1 20050512
DOCDB simple family (application)
FR 0201647 W 20020516; BR 0207438 A 20020516; CA 2447184 A 20020516; CN 02806337 A 20020516; CZ 20032260 A 20020516; EP 02738246 A 20020516; FR 0106506 A 20010517; JP 2002589454 A 20020516; KR 20037010973 A 20030821; US 47765003 A 20031113